Initiating adalimumab in conjunction with clindamycin and rifampicin improves clinical response in Hidradenitis Suppurativa

Published: 7 September 2023| Version 1 | DOI: 10.17632/t4kwnyb7pk.1
Contributor:
Pim Aarts

Description

Supplemental data to: 'Initiating adalimumab in conjunction with clindamycin and rifampicin improves clinical response in Hidradenitis Suppurativa.'

Files

Institutions

Erasmus MC

Categories

Hidradenitis Suppurativa

Licence